November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 20, 2024

New Hope for Hand Function in RA?

Chinese mind-body exercise Yijinjing improved hand function, strength, and flexibility in rheumatoid arthritis patients without exacerbating inflammation

Conexiant

November 20, 2024

4.0 mg/L: The Key to RA Control?

Adalimumab trough levels ≥4.0 mg/L were linked to nearly fourfold higher odds of remission in RA patients, highlighting a potential target for therapeutic drug monitoring.

Conexiant

November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 20, 2024

Ring Gauge Proposed as Simple RA Monitoring Tool

Conexiant

November 20, 2024

RA's Pre-Disease Phase Only Affects Select Patients

Conexiant

November 20, 2024

Low Citrulline T-Cell Levels Tied to Arthritis Risk

Conexiant

November 20, 2024

Genetic GERD Linked to Cardiovascular, Hypertension Risks

Genetically predicted gastroesophageal reflux disease may significantly increase the risk of myocardial infarction and hypertension.

Conexiant